ORIGINAL ARTICLE

High level of anti-helicobacter pylori-heat shock protein 60II3, interferon-γ, and neopterin are risk factors of cardiovascular events in acute coronary syndrome patients

Anak Agung Wiradewi Lestari , I Wayan Wita, Ketut Suata, Ketut Suastika

Anak Agung Wiradewi Lestari
Department of Clinical Pathology, Faculty of Medicine, Universitas Udayana, Sanglah General Hospital, Bali, Indonesia. Email: aa_wiradewi@yahoo.com

I Wayan Wita
Department of Cardiology, Faculty of Medicine, Universitas Udayana, Sanglah General Hospital, Bali, Indonesia

Ketut Suata
Department of Microbiology, Faculty of Medicine, Universitas Udayana, Sanglah General Hospital, Bali, Indonesia

Ketut Suastika
Department of Internal Medicine, Faculty of Medicine, Universitas Udayana, Sanglah General Hospital, Bali, Indonesia
Online First: November 14, 2019 | Cite this Article
Lestari, A., Wita, I., Suata, K., Suastika, K. 2019. High level of anti-helicobacter pylori-heat shock protein 60II3, interferon-γ, and neopterin are risk factors of cardiovascular events in acute coronary syndrome patients. Bali Medical Journal 8(3). DOI:10.15562/bmj.v8i3.1646


Background: Chronic inflammatory process that may cause acute myocardial infarction (AMI) has been known to play an important role in the pathogenesis of atherosclerosis and atheroma plaque instability. Based on inflammation process, several previous studies showed contradictory results in finding a relationship between infection H. pylori with the formation of atherosclerosis through the establishment of immunoglobulin G (IgG) anti-H. pylori-HSP60II3 (IgG anti-Hp-HSP60II3), and neopterin level due to oxidative stress. This study aims to know whether IgG anti-Hp-HSP60II3, IFN-γ and neopterin are risk factors of cardiovascular events (CVE) in patients with ACS.

Methods: A prospective cohort study was conducted among 66 patients to determine the levels of IgG anti-Hp-HSP60II3, IFN-γ, and neopterin in patients with ACS as well as the levels of IgG anti-Hp-HSP60II3, IFN-γ, and neopterin. ACS patients were grouped into two groups: patients with ACS with positive prognostic factors (high levels of IgG anti-Hp-HSP60II3, IFN-γ, neopterin, and hs-CRP) and the group of patients with ACS without prognostic factor (low level of anti-IgG levels hp-HSP60II3, IFN-γ, neopterin, hs-CRP), and then were observed for 6 months while in the hospital. Data were analyzed using SPSS version 20 for Windows.

Results: In observations over a period of 6 months, found as many as 15 (22.7%) patients with CVE, which consisted of 11 (16.7%) patients’ vascular death, 3 (4.5%) patients had IMA and 1 (1.5%) patients experienced recurrent cardiac ischemia from 66 patients with ACS. Mean difference between the time of occurrence CVE subjects with high and low levels of neopterin are statistically significant (P<0.05). When confounding factors such as dyslipidemia, diabetes, hypertension, obesity, smoking, and age are controlled, only neopterin levels affect the incidence CVE with the incidence rate ratio of 6.46 (95% CI: 1.45-28.74; p = 0.014) and path analysis found the effect of neopterin on CVE incidence about 49,1%, p < 0.05. Kaplan-Meier analysis gives result that the average time of CVE on a group of subjects with high levels of neopterin is shorter (129.09 days) than the group of subjects with low levels of neopterin (168.33 days) (P=0.008).

Conclusion: This study found that the high level of anti-helicobacter pylori-heat shock protein 60II3, interferon-γ, and neopterin have a potential role in predicting risk factors of cardiovascular events in acute coronary syndrome patients

References

Okada T, Ayada K, Usui S, Yokota K, Cui J, Kawahara Y, et al. Antibodies against heat shock protein 60 derived from Helicobacter pylori: Diagnostic implications in cardiovascular disease. J Autoimmun. 2007;29(2-3):106-15.

de Boer OJ, van der Wal AC, Becker AE.. Atherosclerosis, inflammation, and infection. J Pathol. 2000;190(3):237-43.

Lamb DJ, El-Sankary W, Ferns GA.. Molecular mimicry in atherosclerosis: a role for heat shock proteins in immunization. Atherosclerosis. 2003;167(2):177-85.

Kleemann R, Zadelaar S, Kooistra T. Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc Res. 2008;79(3):360-76.

Rifai N. High-sensitivity c reactive protein: a useful marker for cardiovascular disease risk prediction. Clin Chem. 2005;51(3):504-5.

de Korwin JD, Ianiro G, Gibiino G, Gasbarrini A. Helicobacter pylori infection and extragastric diseases in 2017. Helicobacter. 2017;22 Suppl 1.

Ayada K, Yokota K, Kobayashi K, Shoenfeld Y, Matsuura E, Oguma K.. Chronic infections and atherosclerosis. Clin Rev Allergy Immunol. 2009;37(1):44-8.

Zhao Y, Yokota K, Ayada K, Yamamoto Y, Okada T, Shen L, et al. Helicobacter pylori heat-shock protein 60 induces interleukin-8 via a toll-like receptor (TLR)2 and mitogen-activated protein (MAP) kinase pathway in human monocytes. J Med Microbiol. 2007;56(Pt 2):154-64.

Ameriso SF, Fridman EA, Leiguarda RC, Sevlever GE.. Detection of Helicobacter pylori in human carotid atherosclerotic plaques. Stroke. 2001;32(2):385-91.

Pasceri V, Cammarota G, Patti G, Cuoco L, Gasbarrini A, Grillo RL, et al. Association of virulent Helicobacter pylori strains with ischemic heart disease. Circulation. 1998;97(17):1675-9.

Snoeckx LH, Cornelussen RN, Van Nieuwenhoven FA, Reneman RS, Van Der Vusse GJ.. Heat shock proteins and cardiovascular pathophysiology. Physiol Rev. 2001;81(4):1461-97.

Pockley AG. Heat shock protein, inflammation and cardiovascular disease. Circulation. 2002;105(8):1012-7.

Harvey, E.J., and Ramji, D.P. 2005. Interferon-gamma and atherosclerosis: pro- or anti-atherogenic? Cardiovasc Res. 2005;67(1):11-20.

Xu Q. Role of heat shock proteins in atherosclerosis. Arterioscler Thromb Vasc Biol. 2002;22(10):1547-59.

Grammer TB, Fuchs D, Boehm BO, Winkelmann BR, Maerz W.. Neopterin as a predictor of total and cardiovascular mortality in individuals undergoing angiography in the Ludwigshafen Risk and Cardiovascular Health Study. Clin Chem. 2009;55(6):1135-46.

Braunwald E. Unstable angina: an etiologic approach to management. Circulation. 1998;98(21):2219-22.

Ozben B, Erdogan O. The role of inflammation and allergy in acute coronary syndromes. Inflamm Allergy Drug Targets. 2008;7(3):136-44.

Nazer B, Ray KK, Sloan S, Scirica B, Morrow DA, Cannon CP, et al. Prognostic utility of neopterin and risk of heart failure hospitalization after an acute coronary syndrome. Eur Heart J. 2011;32(11):1390-7.

Kaski JC, Consuegra-Sanchez L, Fernandez-Berges DJ, Cruz-Fernandez JM, Garcia-Moll X, Marrugat J, et al. Elevated serum neopterin levels and adverse cardiac events at 6 months follow-up in Mediterranean patients with non-ST-segment elevation acute coronary syndrome. Atherosclerosis. 2008;201(1):176-83.

Ray KK, Morrow DA, Sabatine MS, Shui A, Rifai N, Cannon CP, et al Long-term prognostic value of neopterin: a novel marker of monocyte activation in patients with acute coronary syndrome. Circulation. 2007;115(24):3071-8.

Whitman SC, Ravisankar P, Elam H, Daugherty A.. Exogenous Interferon-gamma enhances atherosclerosis in apolipoprotein E -/- mice. Am J Pathol. 2000;157(6):1819-24.

Baidya SG, Zeng QT. Helper T cells and atherosclerosis: the cytokine web. Postgrad Med J. 2005;81(962):746-52.

Pertiwi GAR, Aryawangsa AAN, Prabawa IPY, Manuaba IBAP, Bhargah A, Ratni NWS, Budiana IPG. Factors associated with visit-to-visit variability of blood pressure in hypertensive patients at a Primary Health Care Service, Tabanan, Bali, Indonesia. Family Medicine and Community Health. 2018;6(1):191-199

Handoyo V, Pertiwi GAR, Prabawa IPY, Manuaba IBAP, Bhargah A, Budiana IPG. Management of ST-elevation myocardial infarction in the setting of anterior epistaxis: focused on antiplatelet and antithrombotic therapies. Int Med Case Rep J. 2019;12:33-38.


No Supplementary Material available for this article.
Article Views      : 0
PDF Downloads : 0